Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
21 hedge funds and large institutions have $1.05M invested in Intellipharmaceuticals International Inc. in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 2 closing their positions.
496% more call options, than puts
Call options by funds: $149K | Put options by funds: $25K
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
52% more capital invested
Capital invested by funds: $694K → $1.05M (+$359K)
31% more funds holding
Funds holding: 16 → 21 (+5)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Atria Investments
Charlotte,
North Carolina
|
+$146K |
| 2 |
FFA
First Foundation Advisors
Irvine,
California
|
+$108K |
| 3 |
ATC
Argent Trust Co
Nashville,
Tennessee
|
+$33.6K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$33.6K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$7.65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$97.4K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$19.3K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$13.2K |
| 4 |
Morgan Stanley
New York
|
-$6.23K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.16K |
IPCI Hedge Fund Activity: Q1 2016 in Review
21 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q1 2016, worth a combined $1.05M — up 52% from $694K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new IPCI positions and 2 closed out — a net gain of 5 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Atria Investments, opening a new position worth an estimated $146K. The largest seller was Susquehanna International Group, cutting an estimated $97.4K.
- 21 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q1 2016, up from 16 in Q4 2015.
- Funds reported $1.05M of Intellipharmaceuticals International Inc. stock for Q1 2016, up 52% quarter-over-quarter.
- 7 funds opened new Intellipharmaceuticals International Inc. positions in Q1 2016 and 2 closed out, a net change of +5 holders.
- The largest Intellipharmaceuticals International Inc. buyer in Q1 2016 was Atria Investments, an estimated $146K added.
- The largest Intellipharmaceuticals International Inc. seller in Q1 2016 was Susquehanna International Group, an estimated $97.4K sold.
Based on aggregated 13F filings for Q1 2016.